Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sopharma AD Earnings Release 2023

Apr 20, 2023

2543_rns_2023-04-20_c9027294-81c9-4b6b-aefe-675e948d5c9b.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Current report №19/ 2023 Dated April 20, 2023

NOTIFICATION

"Sopharma" AD (the Company) notifies that for March 2023 the Company recorded an increase in sales of 127% compared to the same month of the previous year, incl. 3% increase in domestic sales and 426% increase in export sales due to the low base in the previous period due to the collapse of sales in the main markets as a result of the conflict between Russia and Ukraine.

For the first three months of 2023, sales increased by a total of 45%, incl. 1% increase of sales for the domestic market and 97% increase in export sales.

Ognian Donev